Topics

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Hidradenitis Suppurativa,Spondylitis, Ankylosing,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised

13:59 EDT 2 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Hidradenitis Suppurativa,Spondylitis, Ankylosing,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Hidradenitis Suppurativa,Spondylitis, Ankylosing,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Hidradenitis Suppurativa,Spondylitis, Ankylosing,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised"

Quick Search

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...